Difficulty: Medium
Average Score: 71%
Practice
Drugs that should not be split include:
Correct answer
D
Rationale
Choice D is correct because enteric-coated tablets (altered absorption), extended-release formulations (disrupted timing), and capsules (uneven dosing) shouldn't be split, risking efficacy or toxicity. Choice A is incorrect alone as it's one type. Choice B is wrong by itself because extended-release is just part. Choice C is incorrect solo since capsules are only one category.